Page last updated: 2024-12-07

as 35

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AS 35: a leukotriene receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130135
SCHEMBL ID159227
SCHEMBL ID20953828
MeSH IDM0198254

Synonyms (23)

Synonym
as 35
as-35
4h-pyrido(1,2-a)pyrimidin-4-one, 9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(1h-tetrazol-5-yl)-
9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one
L003846
9-[(4-acetyl-3-hydroxy-2-propylphenoxy)methyl]-3-(2h-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one
unii-jw517jk7uw
jw517jk7uw ,
108427-72-1
4h-pyrido[1,2-a]pyrimidin-4-one,9-[(4-acetyl-3-hydroxy-2-propylphenoxy)methyl]-3-(2h-tetrazol-5-yl)-
SCHEMBL159227
as35
RVRGDCZGEKSIRW-UHFFFAOYSA-N ,
9-[(4-acetyl-3-hydroxy-2-n-propylphenoxy)methyl]-3-(1h-tetrazol-5-yl)-4h-pyrido[1,2-a]-pyrimidin-4-one
9-[(4-acetyl-3- hydroxy-2-n-propylphenoxy)methyl]-3-(1h-tetrazol-5-yl)-4h-pyrido[1,2-a]pyrimidin-4-one
9-[(4-acetyl-3-hydroxy-2-n-propylphenoxy)methyl]-3-(1h-tetrazol-5-yl)-4h-pyrido[1,2-a]pyrimidin-4-one
DTXSID90148546
HY-101946
CS-7624
4h-pyrido(1,2-a)pyrimidin-4-one, 9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(2h-tetrazol-5-yl)-
9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(1h-1,2,3,4-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one
SCHEMBL20953828
AKOS040741168

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" While pretreatment with inhaled AS-35 (1mg) did not affect the STA2 dose-response curve."( Interaction of thromboxane A2 and leukotrienes in guinea pig airways in vivo.
Bando, T; Fujimura, M; Matsuda, T; Mizuhashi, K, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (88.89)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.31 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index56.82 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (41.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]